GGrantIndex
← Leaderboards

Garret A Fitzgerald

University Of Pennsylvania

$242,218,424
Attributed
$243,226,951
Total exposure
65
Grants
49
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $35.2M · FY200525
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$397,855,787 · 72

By mechanism

UL1$280,543,992 · 29
P01$36,373,090 · 6
P50$34,085,545 · 9
U54$19,769,012 · 2
KL2$9,788,697 · 3
R01$7,682,234 · 4

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchProgramsTranslational ResearchFosteringResponseUniversitiesResearch PersonnelScienceHuman SubjectAwardInstitutionAtherosclerosisPhiladelphiaFundingHome EnvironmentClinical SciencesLeadershipPhenotypeCommunitiesResourcesInstitutesTranslational MedicinePennsylvaniaDiscipline

Grant awards (200)

Institutional Clinical and Translational Science Award$10,230,682
UL1 · FY2025 · TR · contact PI
Institutional Clinical and Translational Science Award$10,230,682
UL1 · FY2024 · TR · contact PI
Institutional Clinical and Translational Science Award$10,247,682
UL1 · FY2023 · TR · contact PI
Institutional Clinical and Translational Science Award$10,260,197
UL1 · FY2022 · TR · contact PI
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade$654,072
R01 · FY2022 · HL · contact PI
Institutional Clinical and Translational Sciences Award$61,306
UL1 · FY2022 · TR · contact PI
Institutional Clinical and Translational Science Award$10,164,477
UL1 · FY2021 · TR · contact PI
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade$669,855
R01 · FY2021 · HL · contact PI
Institutional Clinical and Translational Science Award$177,524
UL1 · FY2021 · TR · contact PI
Institutional Clinical and Translational Science Award$9,938,391
UL1 · FY2020 · TR · contact PI
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade$649,492
R01 · FY2020 · HL · contact PI
Phenotypic Diversity in COVID-19$633,853
UL1 · FY2020 · TR · contact PI
Institutional Clinical and Translational Science Award$161,878
UL1 · FY2020 · TR · contact PI
Institutional Clinical and Translational Science Award$9,954,946
UL1 · FY2019 · TR · contact PI
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade$641,386
R01 · FY2019 · HL · contact PI
Institutional Clinical and Translational Science Award$10,004,097
UL1 · FY2018 · TR · contact PI
Institutional Clinical and Translational Science Award$9,961,031
UL1 · FY2017 · TR · contact PI
Institutional Clinical and Translational Science Award$410,119
UL1 · FY2017 · TR · contact PI
Institutional Clinical and Translational Science Award$9,985,391
UL1 · FY2016 · TR · contact PI
Personalization of Therapeutic Efficacy and Risk$3,666,137
U54 · FY2016 · HL · contact PI
Core A: Administrative$242,082
U54 · FY2016 · HL · contact PI
Institutional Clinical and Translational Science Award$9,885,102
UL1 · FY2015 · TR · contact PI
Personalization of Therapeutic Efficacy and Risk$3,679,818
U54 · FY2015 · HL · contact PI
Institutional Clinical and Translational Science Award$1,070,798
KL2 · FY2015 · TR · contact PI
Core A: Administrative$245,831
U54 · FY2015 · HL · contact PI
Institutional Clinical and Translational Science Award$228,068
TL1 · FY2015 · TR · contact PI
Institutional Clinical and Translational Science Award$9,885,102
UL1 · FY2014 · TR · contact PI
Personalization of Therapeutic Efficacy and Risk$3,699,713
U54 · FY2014 · HL · contact PI
Institutional Clinical and Translational Science Award$638,260
KL2 · FY2014 · TR · contact PI
Core A: Administrative$249,467
U54 · FY2014 · HL · contact PI
Institutional Clinical and Translational Science Award$202,755
TL1 · FY2014 · TR · contact PI
Institutional Clinical and Translational Science Award$120,000
UL1 · FY2014 · TR · contact PI
Institutional Clinical and Translational Science Award$9,094,292
UL1 · FY2013 · TR · contact PI
Personalization of Therapeutic Efficacy and Risk$3,720,420
U54 · FY2013 · HL · contact PI
Signal Transduction in Atherosclerosis$2,158,552
P01 · FY2013 · HL · contact PI
Institutional Clinical and Translational Science Award$1,070,798
KL2 · FY2013 · TR · contact PI
Dynamic Interplay of Eicosanoids in Cardiovasclar Biology$706,142
P01 · FY2013 · HL · contact PI
Institutional Clinical and Translational Science Award$223,273
TL1 · FY2013 · TR · contact PI
Core A: Administrative$217,880
U54 · FY2013 · HL · contact PI
Animal$178,191
P01 · FY2013 · HL · contact PI
Administrative$71,422
P01 · FY2013 · HL · contact PI
ITMAT 2009 - Global Approaches to Translational Research$12,931
R13 · FY2013 · TR · contact PI
Institutional Clinical and Translational Science Award$9,885,102
UL1 · FY2012 · TR · contact PI
Personalization of Therapeutic Efficacy and Risk$3,736,304
U54 · FY2012 · HL · contact PI
Signal Transduction in Atherosclerosis$2,295,305
P01 · FY2012 · HL · contact PI
Institutional Clinical and Translational Science Award$1,070,798
KL2 · FY2012 · TR · contact PI
Dynamic Interplay of Eicosanoids in Cardiovasclar Biology$729,422
P01 · FY2012 · HL · contact PI
Multiscale Analysis of Inter-Clock Communication$490,386
R01 · FY2012 · HL
Core A: Administrative$311,360
U54 · FY2012 · HL · contact PI
Institutional Clinical and Translational Science Award$223,273
TL1 · FY2012 · TR · contact PI
Animal$190,705
P01 · FY2012 · HL · contact PI
Administrative$77,257
P01 · FY2012 · HL · contact PI
ITMAT 2009 - Global Approaches to Translational Research$11,970
R13 · FY2012 · TR · contact PI
Institutional Clinical and Translational Science Award$9,885,103
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$6,179,160
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC CLINICAL TRIALS$2,494,370
UL1 · FY2011 · RR · contact PI
Signal Transduction in Atherosclerosis$2,318,419
P01 · FY2011 · HL · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$785,513
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$785,513
UL1 · FY2011 · RR · contact PI
Dynamic Interplay of Eicosanoids in Cardiovasclar Biology$742,967
P01 · FY2011 · HL · contact PI
Multiscale Analysis of Inter-Clock Communication$502,288
R01 · FY2011 · HL
Institutional Clinical and Translational Science Award$295,510
UL1 · FY2011 · RR · contact PI
Institutional Clinical and Translational Science Award$292,894
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$228,951
UL1 · FY2011 · RR · contact PI
Institutional Clinical and Translational Science Award$220,940
TL1 · FY2011 · RR · contact PI
Animal$196,402
P01 · FY2011 · HL · contact PI
Administrative$78,608
P01 · FY2011 · HL · contact PI
Animal Models and Drug Discovery$35,000
R13 · FY2011 · RR · contact PI
ITMAT 2009 - Global Approaches to Translational Research$10,999
R13 · FY2011 · RR · contact PI
Institutional Clinical and Translational Science Award$1
KL2 · FY2011 · RR · contact PI
Institutional Clinical and Translational Science Award$12,007,471
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$7,511,874
UL1 · FY2010 · RR · contact PI
Lipids as Modulators of the Response to Vascular Injury$3,136,155
P50 · FY2010 · HL · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH$2,628,435
UL1 · FY2010 · RR · contact PI
Signal Transduction in Atherosclerosis$2,354,196
P01 · FY2010 · HL · contact PI
Institutional Clinical and Translational Science Award$1,079,644
KL2 · FY2010 · RR · contact PI
CLINICAL ASPECTS OF ASPIRIN AND CLOPIDOGREL RESISTANCE$900,960
P50 · FY2010 · HL · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$778,084
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$778,084
UL1 · FY2010 · RR · contact PI
Dynamic Interplay of Eicosanoids in Cardiovasclar Biology$755,986
P01 · FY2010 · HL · contact PI
Multiscale Analysis of Inter-Clock Communication$507,360
R01 · FY2010 · HL
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$310,994
UL1 · FY2010 · RR · contact PI
Institutional Clinical and Translational Science Award$218,672
TL1 · FY2010 · RR · contact PI
Animal$201,514
P01 · FY2010 · HL · contact PI
Administrative$80,151
P01 · FY2010 · HL · contact PI
Personalization of Therapeutic Efficacy and Risk$79,875
R24 · FY2010 · GM · contact PI
ITMAT 2009 - Global Approaches to Translational Research$9,990
R13 · FY2010 · RR · contact PI
Institutional Clinical and Translational Science Award$12,110,988
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$7,458,552
UL1 · FY2009 · RR · contact PI
Lipids as Modulators of the Response to Vascular Injury$3,158,571
P50 · FY2009 · HL · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH$2,848,504
UL1 · FY2009 · RR · contact PI
Signal Transduction in Atherosclerosis$2,404,006
P01 · FY2009 · HL · contact PI
Institutional Clinical and Translational Science Award$1,079,644
KL2 · FY2009 · RR · contact PI
Institutional Clinical and Translational Science Award$1,009,381
UL1 · FY2009 · RR · contact PI
CLINICAL ASPECTS OF ASPIRIN AND CLOPIDOGREL RESISTANCE$876,833
P50 · FY2009 · HL · contact PI
Dynamic Interplay of Eicosanoids in Cardiovasclar Biology$773,427
P01 · FY2009 · HL · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$755,120
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$755,120
UL1 · FY2009 · RR · contact PI
Institutional Clinical and Translational Science Award$607,827
UL1 · FY2009 · RR · contact PI
Multiscale Analysis of Inter-Clock Communication$517,021
R01 · FY2009 · HL
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$293,692
UL1 · FY2009 · RR · contact PI
Institutional Clinical and Translational Science Award$217,570
TL1 · FY2009 · RR · contact PI
Animal$205,716
P01 · FY2009 · HL · contact PI
Administrative$81,507
P01 · FY2009 · HL · contact PI
Lipids as Modulators of the Response to Vascular Injury$79,500
P50 · FY2009 · HL · contact PI
ITMAT 2009 - Global Approaches to Translational Research$8,621
R13 · FY2009 · RR · contact PI
Institutional Clinical and Translational Science Award$12,048,641
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$6,315,898
UL1 · FY2008 · RR · contact PI
Lipids as Modulators of the Response to Vascular Injury$3,097,450
P50 · FY2008 · HL · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,972,761
UL1 · FY2008 · RR · contact PI
Signal Transduction in Atherosclerosis$2,297,044
P01 · FY2008 · HL · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH$2,168,273
UL1 · FY2008 · RR · contact PI
Institutional Clinical and Translational Science Award$1,079,644
KL2 · FY2008 · RR · contact PI
CLINICAL ASPECTS OF ASPIRIN AND CLOPIDOGREL RESISTANCE$836,347
P50 · FY2008 · HL · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$591,709
UL1 · FY2008 · RR · contact PI
Dynamic Interplay of Eicosanoids in Atherosclerosis$554,622
P01 · FY2008 · HL · contact PI
Institutional Clinical and Translational Science Award$216,469
TL1 · FY2008 · RR · contact PI
Institutional Clinical and Translational Science Award$12,549,419
UL1 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$9,019,267
UL1 · FY2007 · RR · contact PI
Lipids as Modulators of the Response to Vascular Injury$3,142,980
P50 · FY2007 · HL · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$3,102,217
UL1 · FY2007 · RR · contact PI
Signal Transduction in Atherosclerosis$2,294,361
P01 · FY2007 · HL · contact PI
Institutional Clinical and Translational Science Award$1,079,644
KL2 · FY2007 · RR · contact PI
CLINICAL ASPECTS OF ASPIRIN AND CLOPIDOGREL RESISTANCE$829,818
P50 · FY2007 · HL · contact PI
Dynamic Interplay of Eicosanoids in Atherosclerosis$560,541
P01 · FY2007 · HL · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$427,935
UL1 · FY2007 · RR · contact PI
Lipoxygenases in Atherosclerosis$338,145
R01 · FY2007 · HL · contact PI
Institutional Clinical and Translational Science Award$216,469
TL1 · FY2007 · RR · contact PI
Institutional Clinical and Translational Science Award$9,627,439
UL1 · FY2006 · RR · contact PI
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD$5,295,091
UL1 · FY2006 · RR · contact PI
Lipids as Modulators of the Response to Vascular Injury$3,183,518
P50 · FY2006 · HL · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,888,231
UL1 · FY2006 · RR · contact PI
Signal Transduction in Atherosclerosis$2,279,226
P01 · FY2006 · HL · contact PI
Oxidative Modifications in Atherogenesis$2,206,750
P50 · FY2006 · HL · contact PI
GENERAL CLINICAL RESEARCH CENTER$1,819,110
M01 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL RESEARCH$962,745
UL1 · FY2006 · RR · contact PI
PGD2 and the Response to Vascular Injury$848,902
P50 · FY2006 · HL · contact PI
CLINICAL ASPECTS OF ASPIRIN AND CLOPIDOGREL RESISTANCE$834,753
P50 · FY2006 · HL · contact PI
CTSA: K12 COMPONENT$809,733
KL2 · FY2006 · RR · contact PI
Institutional Clinical and Translational Science Award$809,733
KL2 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$481,372
UL1 · FY2006 · RR · contact PI
Dynamic Interplay of Eicosanoids in Atherosclerosis$380,532
P01 · FY2006 · HL · contact PI
Lipoxygenases in Atherosclerosis$348,245
R01 · FY2006 · HL · contact PI
Nicotine and Oxidative Stress and Endothelial Dysfunction$277,894
P50 · FY2006 · HL · contact PI
Institutional Clinical and Translational Science Award$221,054
TL1 · FY2006 · RR · contact PI
Core--Animal Model$154,748
P50 · FY2006 · HL · contact PI
Administrative Core$72,399
P50 · FY2006 · HL · contact PI
Core C-- Administration Core$48,631
P50 · FY2006 · HL · contact PI
GENERAL CLINICAL RESEARCH CENTER$3,774,788
M01 · FY2005 · RR
Signal Transduction in Atherosclerosis$2,245,959
P01 · FY2005 · HL
Oxidative Modifications in Atherogenesis$2,218,794
P50 · FY2005 · HL
Dynamic Interplay of Eicosanoids in Atherosclerosis$401,760
P01 · FY2005 · HL
Lipoxygenases in Atherosclerosis$356,625
R01 · FY2005 · HL
ACTIVATION OF THROMBOXANE RECEPTOR BY ENDOGENOUS LIGANDS$281,467
P50 · FY2005 · HL
Nicotine and Oxidative Stress and Endothelial Dysfunction$270,996
P50 · FY2005 · HL
Core C-- Administration Core$58,652
P50 · FY2005 · HL
THE DOSE EFFECT OF CIGARETTE-SMOKING ON ARTERIAL FUNCTION AND OXIDATIVE STRESS$55,561
M01 · FY2005 · RR
ACTIVATION OF THROMBOXANE RECEPTOR BY ENDOGENOUS LIGANDS$47,722
M01 · FY2005 · RR
THE THROMBOTIC PROFILES OF CYCLOOXYGENASE INHIBITORS$8,863
M01 · FY2005 · RR
IDENTIFICATION OF SNP'S IN COX-1 AND COX-2 THAT PREDICT RESPONSE TO COXIBS$8,181
M01 · FY2005 · RR
THE VASCULAR BIOLOGY OF DIPYRIDAMOLE IN PERIPHERAL ARTERIAL DISEASE (PAD)$7,499
M01 · FY2005 · RR
ACETAMINOPHEN STUDY$4,772
M01 · FY2005 · RR
THE PHARMACOGENOMICS OF COX INHIBITORS$2,727
M01 · FY2005 · RR
Signal Transduction in Atherosclerosis$2,227,380
P01 · FY2004 · HL
Oxidative Modifications in Atherogenesis$2,145,116
P50 · FY2004 · HL
Dynamic Interplay of Eicosanoids in Atherosclerosis$389,819
P01 · FY2004 · HL
Lipoxygenases in Atherosclerosis$356,625
R01 · FY2004 · HL
ACTIVATION OF THROMBOXANE RECEPTOR BY ENDOGENOUS LIGANDS$274,478
P50 · FY2004 · HL
Nicotine and Oxidative Stress and Endothelial Dysfunction$264,299
P50 · FY2004 · HL
Administration$49,353
P01 · FY2004 · HL
The Dose Effect Of Cigarette-Smoking On Arterial Function And Oxidative Stress$46,874
M01 · FY2004 · RR
Core C-- Administration Core$46,428
P50 · FY2004 · HL
Identification of SNP's in COX-1 and COX-2 that Predict Response to Coxibs$36,931
M01 · FY2004 · RR
The Thrombotic Profiles of Cyclooxygenase Inhibitors$11,008
M01 · FY2004 · RR
Activation of Thromboxane Receptor by Endogenous Ligands$7,812
M01 · FY2004 · RR
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)$4,972
M01 · FY2004 · RR
Oxidative Modifications in Atherogenesis$2,212,959
P50 · FY2003 · HL
SIGNAL TRANSDUCTION IN ATHEROSCLEROSIS$1,419,940
P01 · FY2003 · HL
ISOPROSTANES IN ATHEROSCLEROSIS$428,801
R01 · FY2003 · HL
Nicotine and Oxidative Stress and Endothelial Dysfunction$257,799
P50 · FY2003 · HL
Core C-- Administration Core$55,875
P50 · FY2003 · HL
Oxidative Modifications in Atherogenesis$2,035,391
P50 · FY2002 · HL
SIGNAL TRANSDUCTION IN ATHEROSCLEROSIS$1,374,914
P01 · FY2002 · HL
ISOPROSTANES IN ATHEROSCLEROSIS$417,846
R01 · FY2002 · HL
FOCAL DEFICIENCY IN PGI2 BIOSYNTHESIS$175,153
P01 · FY2002 · HL
CLOPIDOGREL/ASPIRIN INTERACTION IN PTS W PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE$124,146
M01 · FY2002 · RR
TRIAL OF EX VIVO &IN VIVO SELECTIVITY OF COX-1 VS C0X-2 INHIBITION OF RWJ-57504$124,146
M01 · FY2002 · RR
PROSTAGLANDIN G &H SYNTHASE 2 (COX 2) INHIBITOR ON ENDOTOXIN (LPS)$124,146
M01 · FY2002 · RR
INTERACTION OF ASPIRIN W IBUPROFEN, ACETAMINOPHEN OR ROF$124,146
M01 · FY2002 · RR
ACTIVATION OF THROMBOXANE RECEPTOR BY ENDOGENOUS LIGANDS$0
P50 · FY2002 · HL
Nicotine, oxidative stress and endothelial dysfunction$0
P50 · FY2002 · HL
SIGNAL TRANSDUCTION IN ATHEROSCLEROSIS$1,354,173
P01 · FY2001 · HL
ISOPROSTANES IN ATHEROSCLEROSIS$407,209
R01 · FY2001 · HL
FOCAL DEFICIENCY IN PGI2 BIOSYNTHESIS$175,153
P01 · FY2001 · HL
TRIAL OF EX VIVO &IN VIVO SELECTIVITY OF COX-1 VS C0X-2 INHIBITION OF RWJ-57504$124,146
M01 · FY2001 · RR
INTERACTION OF ASPIRIN W IBUPROFEN, ACETAMINOPHEN OR ROF$124,146
M01 · FY2001 · RR
CLOPIDOGREL/ASPIRIN INTERACTION IN PTS W PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE$124,146
M01 · FY2001 · RR
PROSTAGLANDIN G &H SYNTHASE 2 (COX 2) INHIBITOR ON ENDOTOXIN (LPS)$124,146
M01 · FY2001 · RR
PROSTAGLANDIN G &H SYNTHASE 2 (COX 2) INHIBITOR ON ENDOTOXIN (LPS)$0
M01 · FY2001 · RR
ACTIVATION OF THROMBOXANE RECEPTOR BY ENDOGENOUS LIGANDS$0
P50 · FY2001 · HL